SCHEMBL30606157

SCHEMBL30606157

O=C(NC1CC1)c1cnc(Cl)cc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.58
▸ RAB9A P51151 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ P2RX7 Q99572 1/20 0.50
▸ SMYD3 Q9H7B4 4/20 0.46
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA3 P07451 1/20 0.45
▸ CA4 P22748 1/20 0.45
▸ CA6 P23280 1/20 0.45
▸ CA5A P35218 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ CA13 Q8N1Q1 1/20 0.45
▸ CA14 Q9ULX7 1/20 0.45
▸ CA5B Q9Y2D0 1/20 0.45
▸ IRAK4 Q9NWZ3 2/20 0.44
▸ CNR1 P21554 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26100982 1.00 HPGD (0.58) HPGDRAB9ANPC1SMN1; SMN2P2RX7
SCHEMBL21080890 0.94 HPGD (0.52) HPGDRAB9ANPC1SMN1; SMN2P2RX7
SCHEMBL21080891 0.94 HPGD (0.52) HPGDRAB9ANPC1SMN1; SMN2P2RX7
SCHEMBL31171408 0.90 HPGD (0.51) HPGDRAB9ANPC1SMN1; SMN2IRAK4
SCHEMBL21080597 0.89 SMYD3 (0.48) HPGDRAB9ANPC1SMN1; SMN2P2RX7
SCHEMBL21080599 0.89 SMYD3 (0.48) HPGDRAB9ANPC1SMN1; SMN2P2RX7
SCHEMBL31171348 0.88 HPGD (0.47) HPGDRAB9ANPC1SMN1; SMN2P2RX7
SCHEMBL30751129 0.87 HPGD (0.46) HPGDRAB9ANPC1KMT2A
SCHEMBL21161737 0.87 HPGD (0.46) HPGDRAB9ANPC1KMT2A
SCHEMBL31436626 0.83 IRAK4 (0.53) HPGDIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585250-A KIT inhibitors 蓝图药品公司 2025-03-07 — — CN disclosed
EP-4511366-A1 KIT INHIBITORS Blueprint Medicines Corporation (US) 2025-02-26 — — EP disclosed
WO-2023205226-A1 KIT INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2023-10-26 — — WO disclosed
Send feedback